Corrigendum to “HIV remission trial investigators’ attitudes towards risk and risk mitigation in trials that include treatment interruption” [J Virus Erad 9 (2) (June 2023) 100331]
Eunice Akinyi Okumu,
Gail E. Henderson,
Carol Golin,
Kriste Kuczynski,
Nuchanart Q. Ormsby,
Holly L. Peay
Affiliations
Eunice Akinyi Okumu
Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill, USA
Gail E. Henderson
Department of Social Medicine, School of Medicine, University of North Carolina at Chapel Hill, USA; Corresponding author.
Carol Golin
Department of Medicine, School of Medicine, Department of Health Behavior, Gillings Global School of Public Health, University of North Carolina at Chapel Hill, USA; Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill, USA
Kriste Kuczynski
Department of Social Medicine, School of Medicine, University of North Carolina at Chapel Hill, USA
Nuchanart Q. Ormsby
Department of Social Medicine, School of Medicine, University of North Carolina at Chapel Hill, USA
